Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: A strong indicator of underlying HIV infection

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages 346-351

  Lowe, Sara ^a,b   Ferrand, Rashida A ^a,c,d   Morris Jones, Rachael ^e   Salisbury, Jon ^e   Mangeya, Nicholas ^a,c   Dimairo, Munyaradzi ^c   Miller, Robert F ^d,f   Corbett, Elizabeth L ^c,f  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^c BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adolescents; HIV infection; Plane warts; Skin disease

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHEILITIS; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; EPIDEMIC; FEMALE; HERPES SIMPLEX VIRUS 2; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PAPULAR RASH; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SEXUAL BEHAVIOR; SKIN DISEASE; SKIN EXAMINATION; VERRUCA VULGARIS; ZIMBABWE;

EID: 77950281417     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181c15da4     Document Type: Article

References (39)

1. Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet. 1996;348:659-663.
2. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with the human immunodeficiency virus. Arch Dermatol. 1988;125:357-361.
3. Goh BK, Chan R, Sen P, et al. Spectrum of skin disorders in human immunodeficiency virus infected patients in Singapore and their relationship to CD4 lymphocyte counts. Int J Dermatol. 2007;46:695-699.
4. Raju PV, Rao GR, Ramani TV, et al. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. 2005;44:646-649.
5. Goldstein B, Berman B, Sukenik E, et al. Correlation of skin disorders with CD4 lymphocyte count in patients with HIV/AIDS. J Am Acad Dermatol. 1997;36:262-264.
6. Shah I. Correlation of CD4 count, CD4% and HIV viral load with clinical manifestations of HIV in infected Indian children. Ann Trop Paediatr. 2006;26:115-119.
7. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infections with CD4 counts and disease progression. Int J Dermatol. 2007;46(suppl 2):14-18.
8. Muhammad B, Eligius L, Mugusi F, et al. The prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in Dar es Salaam. Trop Doct. 2003;33:44-48.
9. Josephine M, Issac E, George A, et al. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45:280-284.
10. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, et al. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139:33-39.
11. WHO. Case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV related disease in adults and children. WHO. Geneva, Switzerland, August 2006.
12. Freytes DM, Arroyo-Novoa CM, Figueroa-Ramos MI, et al. Skin disease in HIV-positive persons living in Puerto Rico. Adv Skin Wound Care. 2007; 20:149-156.
13. Wananukul S, Deekajorndech T, Panchareon C, et al. Mucocutaneous findings in pediatric AIDS related to degree of immunosupression. Pediatr Dermatol. 2003;20:289-294.
14. Emodi IJ, Okafor GO. Clinical manifestations of HIV infection in children at Enugu, Nigeria. J Trop Pediatr. 1998;44:73-76.
15. Tzung T, Yang C, Chao S, et al. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan. Kaohsiung J Med Sci. 2004; 20:216-223.
16. UNAIDS. AIDS epidemic update. UNAIDS. Geneva, Switzerland, November 2007.
17. Newell ML, Coovadia H, Cortina-Borja M, et al; Ghent International AIDS Society (IAS) Working Group in HIV Infection in Women and Children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;369:1236-1243.
18. Marston M, Zaba B, Salomon JA, et al. Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr. 2005;38:219-227.
19. Stover J, Walker N, Grassly NC, et al. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect. 2006;82(suppl 3):iii45-iii50.
20. Ferrand RA, Mafukidze A, Mangeya N, et al. Causes of acute hospitaliza-tion during adolescence; the burden and spectrum of HIV related morbidity in a country with an early and severe HIV epidemic. Poster presented at: Meeting of Royal Society of Tropical Medicine and Hygiene; September 2008; Brighton, United Kingdom.
21. Walker S, Mulenga V, Sinyinza F, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial. J Acquir Immune Defic Syndr. 2006;42:637-645.
22. Ferrand R, Luethy R, Bwakura F, et al. HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis. 2007;44:874-878.
23. Bagenda D, Nassali A, Kalyesubula I, et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving and antiretroviral-naive Ugandan children. Pediatrics. 2006;117:729-740.
24. Fielden SJ, Sheckter L, Chapman GE, et al. Growing up: perspectives of children, families and service providers regarding the needs of older children with perinatally-acquired HIV. AIDS Care. 2006;18:1050-1053.
25. Ankrah ME. The impact of HIV/AIDS on the family and other significant relationships: the African clan revisited. AIDS Care. 1993;5:5-22.
26. Auvert B, Ballard R, Campbell C, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS. 2001;15:931-934.
27. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis. 1999;179:16-24.
28. Hira SK, Wadhawan D, Kamanga J, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol. 1988;19:451-457.
29. Judd A, Ferrand R, Jungmann E, et al. Vertically acquired HIV diagnosed in adolescence and early adulthood: findings from national surveillance. HIV Med. 2009;10:253-256.
30. Boonchai W, Laohasrisakul R, Manonukul J, et al. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol. 1999;38:348-350.
31. Mangeya N, Mafukidze A, Makunike-Mutasa R, et al. Chronic knee stiffness and swelling in a Zimbabwean adolescent. Int J STD AIDS. 2009;20:63-64.
32. Carre D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol. 2003;42:296-300.
33. Resneck JS, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004;292:2614-2621.
34. Castelnuovo B, Byakwaga H, Menten J, et al. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? AIDS. 2008;22:269-273.
35. Seoane Reula E, Bellon JM, Gurbindo D, et al. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. Br J Dermatol. 2005;153:382-389.
36. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunedeficient HIV-infected patients with highly active antiretroviral therapy in an HIV-infected patient. HIV Med. 2000;1:107-115.
37. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21:54-59.
38. Reid D, Mosam A, Nelson R. Quality of life in patients with HIV and skin disease. J Am Acad Dermatol. 2006;53:AB60.
39. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155:145-151.